· By Sanofi Admin

Drug Development 101: Phase 3 Clinical Trials

This post was authored by Terttu Haring, Vice President in Clinical Sciences & Operations, Global Head Trial Operations, Sanofi
If you have been following along with our Drug Development 101 blog series, you will know that we shed light on preclinical research, Phase 1 clinical trials and Phase 2 clinical trials over the course of past […]

VIEW FULL POST
 · By Sanofi Admin

Drug Development 101: Phase 2 Clinical Trials

Author: Kristin Schuhwerk, VP, Global Head of Clinical Operations, Sanofi
This past November, my colleague Paul Deutsch shared some valuable information about Phase 1 clinical trials, as part of our Drug Development 101 series. Today, I’d like to build on this information by providing some insight on what comes after Phase 1 clinical trials – Phase […]

VIEW FULL POST